Gabon vs Madagascar: HIV/AIDS deaths averted by antiretroviral therapy
Gabon
2,398 deaths
in 2024
Madagascar
2,165 deaths
in 2024
Gabon rank
53rd
Madagascar rank
55th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Gabon
- Madagascar
How they compare
Gabon currently reports 2,398 deaths against 2,165 deaths in Madagascar, a difference of 233 deaths.
That makes Gabon's figure about 1.1 times Madagascar's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Madagascar ahead.
Gabon ranks 53rd and Madagascar ranks 55th of 157 countries.
Gabon has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Gabon | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 658.44 deaths | 14.82 deaths | 643.62 deaths | Gabon |
| 2010s | 2,011 deaths | 196.24 deaths | 1,815 deaths | Gabon |
| 2020s | 2,106 deaths | 1,309 deaths | 797.37 deaths | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Gabon or Madagascar?
- Gabon, at 2,398 deaths against 2,165 deaths in Madagascar as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Gabon and Madagascar?
- 233 deaths, with Gabon ahead.
- How many years of comparable data are there for Gabon and Madagascar?
- 35 years are reported by both, from 1990 to 2024.
- How do Gabon and Madagascar rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Gabon ranks 53rd and Madagascar ranks 55th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.